- Home
- FLS vs HALO Comparison
FLS vs HALO Comparison
Compare FLS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLS
- HALO
- Stock Information
- Founded
- FLS 1790
- HALO 1998
- Country
- FLS United States
- HALO United States
- Employees
- FLS N/A
- HALO N/A
- Industry
- FLS Fluid Controls
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLS Industrials
- HALO Health Care
- Exchange
- FLS Nasdaq
- HALO Nasdaq
- Market Cap
- FLS 8.3B
- HALO 7.4B
- IPO Year
- FLS N/A
- HALO N/A
- Fundamental
- Price
- FLS $42.31
- HALO $58.41
- Analyst Decision
- FLS Strong Buy
- HALO Buy
- Analyst Count
- FLS 10
- HALO 9
- Target Price
- FLS $64.30
- HALO $61.75
- AVG Volume (30 Days)
- FLS 1.8M
- HALO 1.6M
- Earning Date
- FLS 04-29-2025
- HALO 05-06-2025
- Dividend Yield
- FLS 1.99%
- HALO N/A
- EPS Growth
- FLS 50.70
- HALO 63.33
- EPS
- FLS 2.14
- HALO 3.43
- Revenue
- FLS $4,557,806,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- FLS $6.94
- HALO $20.06
- Revenue Next Year
- FLS $4.72
- HALO $24.04
- P/E Ratio
- FLS $19.70
- HALO $16.94
- Revenue Growth
- FLS 5.49
- HALO 22.44
- 52 Week Low
- FLS $37.34
- HALO $37.97
- 52 Week High
- FLS $65.08
- HALO $66.00
- Technical
- Relative Strength Index (RSI)
- FLS 40.55
- HALO 44.19
- Support Level
- FLS $39.85
- HALO $56.47
- Resistance Level
- FLS $43.68
- HALO $62.14
- Average True Range (ATR)
- FLS 2.70
- HALO 2.86
- MACD
- FLS 0.19
- HALO -0.39
- Stochastic Oscillator
- FLS 46.58
- HALO 36.34
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.